Liver Damage in a Person Taking the Diabetes Drug Rosiglitazone FREE

High levels of blood sugar in diabetic patients contribute over time to such complications as blindness and kidney failure. The goal of diabetes treatment is therefore to keep blood sugar levels normal, but treatment often involves daily injections of insulin. The thiazolidinediones are a new class of diabetes drugs in pill form that lower blood sugar levels. Unfortunately, the first approved drug in this class, troglitazone, can cause severe liver damage in small percentage of people. It is not yet known whether the second drug in this class, rosiglitazone, is associated with severe liver problems.

The authors observed liver damage in a patient taking rosiglitazone.

A 69-year-old man who had been taking rosiglitazone, 4 mg per day.

The authors reviewed the patient's medical records.

After taking rosiglitazone for 1 week, the patient had developed abdominal pain, nausea, loss of appetite, and fatigue. His symptoms worsened over time, and he stopped taking the medication after 3 weeks. Five days later, he was admitted to the hospital with abdominal pain and shortness of breath, and rapidly became comatose. He also developed an abnormally slow heart rate and low blood pressure. In addition to diabetes, his previous medical problems included high blood pressure, coronary artery disease, and an abnormal heart rhythm (atrial fibrillation). Blood tests in the hospital for liver damage were extremely abnormal; they had been normal before the patient began rosiglitazone.

The patient was treated with supportive care, and tests were done for other possible causes of the liver damage. None of these tests was positive. The doctors therefore concluded that the liver damage was due to either a toxic reaction to rosiglitazone, the episode of low blood pressure, or possibly a combination of the two. The patient's liver tests became normal over two weeks, and he eventually recovered completely.

It is impossible to know with certainty in this single patient whether rosiglitazone, low blood pressure, or some other factor was responsible for his liver failure. For example, the patient was taking other drugs, including pravastatin, verapamil, betaxolol, digoxin, and warfarin, at the time the liver damage occurred; one or more of these drugs could have contributed to the problem.

Liver damage may possibly occur in patients who take rosiglitazone. Patients taking this drug should have their liver tests watched carefully and should stop taking the drug if symptoms develop.